Aqueous Humor Cytokine Profiling Reveals Distinct Roles for Serum Amyloid A, Interleukin-8, and Endothelin-1 in Pseudoexfoliation Syndrome and Glaucoma

被引:0
作者
Kadoh, Yoichi [1 ]
Takayanagi, Yuji [1 ]
Sugihara, Kazunobu [1 ]
Kaidzu, Sachiko [1 ]
Takai, Yasuyuki [1 ]
Tanito, Masaki [1 ]
机构
[1] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo 6938501, Japan
关键词
pseudoexfoliation syndrome; glaucoma; exfoliation glaucoma; inflammatory cytokines; aqueous humor; Serum Amyloid A (SAA); Interleukin-8 (IL-8); Endothelin-1 (ET-1); Vascular Endothelial Growth Factor (VEGF); NORMAL-TENSION; NITRIC-OXIDE; STRESS; RISK;
D O I
10.3390/ijms26041461
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pseudoexfoliation syndrome (PE), which is often unilateral in 60% of cases, is a risk for exfoliation glaucoma (EXG) with elevated inflammatory cytokines. This study aimed to clarify the dynamics of these cytokines in unilateral PE (u-PE) patients. This study included 20 eyes from 10 u-PE patients (PE+ eyes and fellow PE- eyes) and 20 eyes from 10 cataract patients without PE (control group). Clinical parameters, including age, visual acuity, and intraocular pressure, were assessed. Anterior chamber aqueous humor cytokine levels (IL-8, SAA, ET-1, VEGF) were measured and compared among groups. SAA was elevated in PE+ eyes compared to PE- and control eyes. IL-8 and ET-1 were elevated in both PE+ and PE- eyes compared to controls. IL-8 was associated with worsening visual acuity, while ET-1 correlated inversely. Our findings suggest that SAA is associated with the manifest disease while IL-8 and ET-1 could be early biomarkers for PE and therapeutic targets to prevent glaucomatous damage, as these markers appear in the aqueous humor even before pseudoexfoliation material becomes clinically evident. These results may enable earlier diagnosis and therapeutic intervention before the clinical onset of PE in patients with risk factors.
引用
收藏
页数:10
相关论文
共 32 条
  • [21] Liu Q., Sun S., Yang Z., Shao Y., Li X., Serum Amyloid A 4 as a Common Marker of Persistent Inflammation in Patients with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy, J. Inflamm. Res, 16, pp. 3783-3797, (2023)
  • [22] Amer R., Koriat A., Aqueous humor perturbations in chronic smokers: A proteomic study, Sci. Rep, 14, (2024)
  • [23] Zenkel M., Lewczuk P., Junemann A., Kruse F.E., Naumann G.O., Schlotzer-Schrehardt U., Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma, Am. J. Pathol, 176, pp. 2868-2879, (2010)
  • [24] Sugiyama T., Moriya S., Oku H., Azuma I., Association of endothelin-1 with normal tension glaucoma: Clinical and fundamental studies, Surv. Ophthalmol, 39, pp. S49-S56, (1995)
  • [25] Borazan M., Karalezli A., Kucukerdonmez C., Bayraktar N., Kulaksizoglu S., Akman A., Akova Y.A., Aqueous humor and plasma levels of vascular endothelial growth factor and nitric oxide in patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma, J. Glaucoma, 19, pp. 207-211, (2010)
  • [26] Tsutsui A., Hamanaka T., Kaidzu S., Kobayashi K., Ishida N., Kumasaka T., Tanito M., Comparison of Schlemm’s Canal Morphology Parameters Between Propensity Score-Matched Primary Open-Angle Glaucoma and Exfoliation Glaucoma, Investig. Ophthalmol. Vis. Sci, 65, (2024)
  • [27] Dismuke W.M., Liang J., Overby D.R., Stamer W.D., Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility, Exp. Eye Res, 120, pp. 28-35, (2014)
  • [28] Agilli M., Aydin F.N., Cayci T., Gulcan Kurt Y., Evaluation of serum amyloid a as a marker of persistent inflammation in patients with rheumatoid arthritis, Mediat. Inflamm, 2015, (2015)
  • [29] Gremese E., Tolusso B., Bruno D., Perniola S., Ferraccioli G., Alivernini S., The forgotten key players in rheumatoid arthritis: IL-8 and IL-17—Unmet needs and therapeutic perspectives, Front. Med, 10, (2023)
  • [30] Park D.Y., Kim M., Cha S.C., Cytokine and Growth Factor Analysis in Exfoliation Syndrome and Glaucoma, Investig. Ophthalmol. Vis. Sci, 62, (2021)